Tarsus Submits NDA to the FDA for Demodex Blepharitis Drug Candidate

Name: Tarsus Submits NDA to the FDA for Demodex Blepharitis Drug Candidate
Uploaded: 2022-09-14T14:41:28+00:00

Show Description +

Posted: 9/14/2022

Posted: 9/14/2022

Please log in to leave a comment.